Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?
The results of this study demonstrate that multimorbidity is strongly related to the occurrence of ADEs, insofar as it requires the intervention of multiple specialties and the prescription of  multiple medications. Further research should shed light on the causal pathway between multimorbidity and increased risk of adverse events.
Oral administration of VSL#3 was effective as primary therapy in IL-10 gene-deficient mice, and had a direct effect on epithelial barrier function.